Swiss All Share Index
15.463,65
PKT
-128,25
PKT
-0,82
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
09.04.20 | UBS overweight | Morgan Stanley | |
09.04.20 | UBS Equal-Weight | Morgan Stanley | |
09.04.20 | Nestlé overweight | Morgan Stanley | |
09.04.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
09.04.20 | UBS buy | Kepler Cheuvreux | |
09.04.20 | Roche overweight | Barclays Capital | |
09.04.20 | UBS Outperform | Credit Suisse Group | |
09.04.20 | Zurich Insurance Outperform | Credit Suisse Group | |
09.04.20 | Swiss Re Outperform | Credit Suisse Group | |
09.04.20 | Givaudan buy | UBS AG | |
08.04.20 | Givaudan Underperform | Credit Suisse Group | |
08.04.20 | Givaudan buy | UBS AG | |
08.04.20 | UBS buy | UBS AG | |
08.04.20 | Givaudan add | Baader Bank | |
08.04.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
08.04.20 | Holcim buy | Oddo BHF | |
08.04.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
08.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
08.04.20 | Givaudan Underperform | Bernstein Research | |
08.04.20 | Nestlé Hold | HSBC | |
08.04.20 | Holcim kaufen | JP Morgan Chase & Co. | |
07.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
07.04.20 | Givaudan Underweight | Barclays Capital | |
07.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
07.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.20 | Holcim buy | Goldman Sachs Group Inc. | |
06.04.20 | Givaudan add | Baader Bank | |
06.04.20 | Novartis Hold | Deutsche Bank AG | |
06.04.20 | Roche buy | Deutsche Bank AG | |
06.04.20 | Nestlé overweight | JP Morgan Chase & Co. | |
06.04.20 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
03.04.20 | Swiss Re Sector Perform | RBC Capital Markets | |
03.04.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
03.04.20 | Roche overweight | Barclays Capital | |
03.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
02.04.20 | Swiss Re Sector Perform | RBC Capital Markets |